Chartwell Investment Partners, LLC Alx Oncology Holdings Inc Transaction History

Chartwell Investment Partners, LLC

  • $2.91 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$21.49 - $74.4 $113,682 - $393,576
-5,290 Closed
0 $0
Q2 2021

Jul 19, 2021
BUY
$52.2 - $75.23 $2,453 - $3,535
47 Added 0.9%
5,290 $289,000
Q1 2021

May 03, 2021
SELL
$62.84 - $87.68 $17,658 - $24,638
-281 Reduced 5.09%
5,243 $387,000
Q4 2020

Feb 09, 2021
BUY
$34.11 - $112.26 $188,423 - $620,124
5,524 New
5,524 $476,000

Others Institutions Holding ALXO

# of Institutions
96
Shares Held
39.5M
Call Options Held
213K
Put Options Held
44.8K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $43.2M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email